Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
06/2014
06/12/2014US20140163048 Compositions with increased stability for inhibiting transient receptor potential ion channel trpa1
06/12/2014US20140158116 Inhibiting trpa1 for the treatment of asthma
06/11/2014CN103857396A Inhibitors of bruton's tyrosine kinase
06/11/2014CN103848831A Doxofylline compound and pharmaceutical composition thereof
06/11/2014CN102405217B Azaazulene compounds
06/10/2014US8748411 Antineoplastic compounds and pharmaceutical compositions thereof
06/05/2014WO2014083554A1 Stable amorphous form of linagliptin
06/05/2014WO2014083327A1 Adenine derivatives suitable for the treatment of (inter alia) muscular dystrophy
06/05/2014US20140155605 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
06/05/2014US20140155395 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
06/05/2014US20140155394 Chemical Compounds - 759
06/05/2014US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta
06/04/2014CN102711766B N-9-substituted purine compounds, compositions and methods of use
06/04/2014CN101889015B Pyrimidine substituted purine derivatives
06/04/2014CN101862345B Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
05/2014
05/30/2014WO2014033746A3 Process for preparation of dipeptidylpeptidase inhibitors
05/29/2014US20140148433 Bicyclic aza heterocycles, and use thereof
05/29/2014US20140148410 Supramolecular Nanofibers and Hydrogels Based on Nucleic Acids Functionalized with Nucleobases
05/28/2014CN103819472A 缬恩替卡韦酸式加成盐及其制备方法 Valerian entecavir acid addition salts and its preparation method
05/28/2014CN103819440A 杨梅素药物共晶及其制备方法 Myricetin drug eutectic and its preparation method
05/28/2014CN102827165B 一种膜技术定向制备茶碱-糖精共晶的方法 Directed the preparation of a membrane technology theophylline - saccharin eutectic methods
05/28/2014CN102702198B 一种咖啡因甲化母液清洁处理的工艺及其设备 One kind of liquor caffeine A clean processing technology and equipment
05/27/2014US8735407 Purine derivatives as A3 adenosine receptor-selective agonists
05/27/2014US8735406 8-oxodihydropurine derivative
05/27/2014CA2758986C Inhibitors of pi3 kinase and/or mtor
05/22/2014WO2014075393A1 Purine inhibitors of human phosphatidylinositol 3-kinase delta
05/22/2014WO2014075392A1 Purine inhibitors of human phosphatidylinositol 3-kinase delta
05/22/2014US20140142307 Azolium and purinium salt anticancer and antimicrobial agents
05/22/2014US20140142099 Purinone Derivatives as Tyrosine Kinase Inhibitors
05/22/2014US20140142098 Triazolopyrazine
05/22/2014US20140141033 Conjugated tlr7 and/or tlr8 and tlr2 agonists
05/21/2014EP2732825A1 Conjugated TLR7 and/or TLR8 and TLR2 agonists
05/21/2014EP2731947A1 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
05/21/2014EP2731612A2 Inhibitors of bruton's tyrosine kinase
05/21/2014CN103804380A 以IKK-β为靶点的2-氨基-8-取代鸟嘌呤衍生物、应用及其制备方法 In IKK-β as a target of 2-amino-8-substituted guanine derivatives, application and preparation method
05/21/2014CN102245580B O<sup>6</sup>-烷基鸟嘌呤-DNA烷基转移酶及其突变体的底物 O <sup> 6 </ sup> - alkyl guanine -DNA alkyl transferase and mutant substrates
05/20/2014US8729088 Toll-like receptor modulators and treatment of diseases
05/15/2014US20140135492 Modulators of toll-like receptor 7
05/15/2014US20140135301 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/14/2014EP2729459A1 Substituted azaheterocycles for the treatment of cancer
05/14/2014CN103788096A 一种盐酸缬更昔洛韦的合成方法 A synthesis method of valganciclovir hydrochloride
05/14/2014CN103788095A 2,4(1h,3h)-嘧啶二酮衍生物及其制备方法 2,4 (1h, 3h) - pyrimidine-dione derivatives and their preparation
05/14/2014CN102732523B 特异性识别玉米素的核酸适体及其筛选方法和应用 Specific recognition zeatin aptamer and its screening methods and applications
05/14/2014CN101827949B 核碱基表征 Characterization of nucleobases
05/13/2014CA2795006C Purine compounds used as cb2 agonists
05/13/2014CA2618524C Pyrazole derivatives having tyrosine kinase activity
05/08/2014WO2013013009A3 2',3'-DIDEOXY-2'-α-FLUORO-2'-β-C-METHYLNUCLEOSIDES AND PRODRUGS THEREOF
05/08/2014US20140128604 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
05/08/2014US20140128570 Conformationally-preorganized, minipeg-containing gamma-peptide nucleic acids
05/08/2014US20140128408 Hdac inhibitors and therapeutic methods using the same
05/08/2014US20140128390 Compounds and methods for kinase modulation, and indications therefor
05/08/2014US20140128389 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
05/07/2014CN103781788A 经取代的喹唑啉、其制备及其在药物组合物中的用途 Substituted quinazoline, their preparation and their use in pharmaceutical compositions
05/07/2014CN101516850B 适用作e1活化酶抑制剂的杂芳基化合物 Activating enzyme inhibitors suitable for e1 heteroaryl compound
05/06/2014US8716300 Frequency modulated drug delivery (FMDD)
05/06/2014CA2644333C Reaction reagent for trifluoromethylation
05/01/2014US20140121226 Substituted xanthine derivatives
05/01/2014US20140121225 Polymorph of linagliptin benzoate
05/01/2014US20140121224 Quinazolinones as inhibitors of human phosphatidyositol 3-kinase delta
05/01/2014US20140121223 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
05/01/2014US20140120083 Treatment of cancers using pi3 kinase isoform modulators
05/01/2014US20140120060 Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors
04/2014
04/30/2014CN103755705A Total synthesis method for natural product tetramethyl uric acid
04/30/2014CN102659785B 2-amino-6-aminomethylpurine compound and preparation method and application thereof
04/29/2014US8710063 Purine compounds used as CB2 agonists
04/29/2014CA2777018C Novel method for preparing entecavir and intermediate used therein
04/24/2014WO2014059938A1 Method for preparing important intermediate of linagliptin
04/24/2014US20140114070 Compounds that expand hematopoietic stem cells
04/24/2014US20140113917 Pyrazole compounds as crth2 antagonists
04/23/2014CN103739603A Preparation method of hepatitis B therapeutic entecavir
04/22/2014US8703942 Small-molecule Hsp90 inhibitors
04/22/2014US8703777 Certain chemical entities, compositions and methods
04/22/2014US8703754 6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
04/22/2014US8703158 Theobromine for the treatment of cough
04/17/2014WO2014056333A1 Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor
04/17/2014US20140107115 Novel immune system modulators
04/17/2014US20140107098 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
04/17/2014US20140105898 Apoptosis-inducing molecules and uses therefor
04/16/2014CN103732594A Tenofovir alafenamide hemifumarate
04/16/2014CN103724348A Method for preparing theobromine
04/16/2014CN102256977B Purine compounds
04/15/2014US8697911 Rho kinase inhibitors
04/15/2014US8697868 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/15/2014US8697675 Tenofovir alafenamide hemifumarate
04/10/2014WO2014055548A1 Anti-fibrotic pyridinones
04/10/2014WO2014053222A1 Phospholipid drug analogs
04/10/2014US20140100237 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
04/10/2014US20140100224 Neurotrophin mimetics and uses thereof
04/09/2014EP2714691A1 Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir
04/09/2014EP2714686A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
04/09/2014EP2713737A1 Novel immune system modulators
04/09/2014CN103709164A Synthetic method for adenine
04/09/2014CN103709163A Xanthine derivative, preparation method thereof and uses thereof
04/09/2014CN102365283B Novel crystal forms of adefovir dipivoxil and processes for preparing same
04/03/2014WO2014048243A1 Xanthine derivative, preparation method and use thereof
04/03/2014US20140094475 Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
04/02/2014CN103702989A Novel compounds as modulators of protein kinases
04/02/2014CN102584825B Method for synthesizing valaciclovir hydrochloride
04/02/2014CN102227427B Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 120